Nanalysis and The United States Pharmacopeia (USP) Co-Publish Study Demonstrating Efficacy of Benchtop NMR for Quality Control
Portfolio Pulse from
Nanalysis Scientific Corp. and the United States Pharmacopeia have co-published a study showing the efficacy of benchtop NMR for quality control in pharmaceuticals. This technology is expected to become a significant tool in the pharmaceutical quality control market.
December 11, 2024 | 1:45 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Nanalysis Scientific Corp. has co-published a study with USP demonstrating the efficacy of benchtop NMR for pharmaceutical quality control, potentially increasing its market presence.
The study's positive results highlight the potential for Nanalysis's benchtop NMR technology to become a key tool in the pharmaceutical industry, which could lead to increased demand and market share for the company.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90